Indinavir

CD4 molecule ; Homo sapiens







38 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 22743598 Enhanced anti-HIV efficacy of indinavir after inclusion in CD4-targeted lipid nanoparticles. 2012 Dec 1 7
2 19194315 Depletion of CD4+ T cells in semen during HIV infection and their restoration following antiretroviral therapy. 2009 Mar 1 2
3 18097230 Efficacy and tolerability of long-term efavirenz plus nucleoside reverse transcriptase inhibitors for HIV-1 infection. 2008 Jan 11 2
4 17885295 Prevalence and factors associated with dry skin in HIV infection: the FRAM study. 2007 Oct 1 5
5 16760797 Optimization of lipid-indinavir complexes for localization in lymphoid tissues of HIV-infected macaques. 2006 Jun 1
6 16430196 Efficacy and safety of indinavir/ritonavir 400/100 mg twice daily plus two nucleoside analogues in treatment-naive HIV-1-infected patients with CD4+ T-cell counts <200 cells/mm3: 96-week outcomes. 2005 2
7 14571186 Six-year follow-up of HIV-1-infected adults in a clinical trial of antiretroviral therapy with indinavir, zidovudine, and lamivudine. 2003 Nov 7 1
8 11956511 CD4 response is correlated with peak plasma concentrations of indinavir in adults with undetectable human immunodeficiency virus ribonucleic acid. 2002 Apr 2
9 12047144 Urinary cytology associated with human polyomavirus and indinavir therapy in HIV-infected patients. 2002 Jun 3
10 12685114 [Renal lithiasis due to indinavir]. 2002 Jul-Sep 1
11 11491415 Antiretroviral activity and safety of abacavir in combination with selected HIV-1 protease inhibitors in therapy-naive HIV-1-infected adults. 2001 Jun 1
12 10681350 Indinavir pharmacokinetics and parmacodynamics in children with human immunodeficiency virus infection. 2000 Mar 1
13 10742724 Randomized, double-blind trial comparing indinavir alone, zidovudine alone and indinavir plus zidovudine in antiretroviral therapy-naive HIV-infected individuals with CD4 cell counts between 50 and 250/mm3. 2000 Jan-Feb 2
14 10770538 AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients. 2000 Mar 10 1
15 10823790 High levels of drug-resistant human immunodeficiency virus variants in patients exhibiting increasing CD4+ T cell counts despite virologic failure of protease inhibitor-containing antiretroviral combination therapy. 2000 May 1
16 10983634 Dynamics of HIV-1 viral load rebound among patients with previous suppression of viral replication. 2000 Jul 28 1
17 11064501 Comparison of immunologic restoration and virologic response in plasma, tonsillar tissue, and cerebrospinal fluid in HIV-1-infected patients treated with double versus triple antiretroviral therapy in very early stages: The Spanish EARTH-2 Study. Early Anti-Retroviral Therapy Study. 2000 Sep 1 1
18 11118067 A randomized trial comparing the introduction of ritonavir or indinavir in 1251 nucleoside-experienced patients with advanced HIV infection. 2000 Nov 20 1
19 11148725 Indinavir urolithiasis. 2000 Nov 1
20 9878015 Prolonged suppression of human immunodeficiency virus type 1 (HIV-1) viremia in persons with advanced disease results in enhancement of CD4 T cell reactivity to microbial antigens but not to HIV-1 antigens. 1999 Feb 1
21 10357371 Randomized trial comparing saquinavir soft gelatin capsules versus indinavir as part of triple therapy (CHEESE study). 1999 May 7 1
22 10481407 [Granular lymphocyte-proliferative disorder following initiation of protease inhibitor therapy in a patient with acquired immunodeficiency syndrome]. 1999 Jul 1
23 9456253 Improvement of chronic diarrhoea in patients with advanced HIV-1 infection during potent antiretroviral therapy. 1998 Jan 1 1
24 9457095 Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease. 1998 Jan 24 2
25 9617598 Amprenavir. 1998 Jun 1
26 9651421 A phase I/II study of the protease inhibitor indinavir in children with HIV infection. 1998 Jul 1
27 9660361 Simultaneous vs sequential initiation of therapy with indinavir, zidovudine, and lamivudine for HIV-1 infection: 100-week follow-up. 1998 Jul 1 1
28 9801897 Cicatrization of cytomegalovirus retinitis following introduction of highly active anti-retroviral therapy: uveitis as a possible indicator of good ocular prognosis. 1998 Oct 2
29 9878993 Efavirenz. 1998 Dec 1
30 10682133 Improvement in immune function due to treatment with indinavir despite severe immune deficiency. 1998 1
31 11365923 Indinavir--study highlights importance of CD4+ counts over viral load. 1998 Nov 1
32 9021206 Modeling of the change in CD4 lymphocyte counts in patients before and after administration of the human immunodeficiency virus protease inhibitor indinavir. 1997 Feb 3
33 9084796 Change in circulating levels of the chemokines macrophage inflammatory proteins 1 alpha and 11 beta, RANTES, monocyte chemotactic protein-1 and interleukin-16 following treatment of severely immunodeficient HIV-infected individuals with indinavir. 1997 Mar 15 1
34 9250556 Drug interaction potential with inhibitors of HIV protease. 1997 Jul-Aug 1
35 9287227 A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. 1997 Sep 11 2
36 9287228 Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. 1997 Sep 11 1
37 9386799 Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patients. 1997 Nov 15 1
38 8881129 [HIV protease inhibitors: general review]. 1996 May-Jun 1